310823285	310823285	CD	B-NP	O
|	|	NN	I-NP	O
MMC	MMC	NN	I-NP	O
|	|	NN	I-NP	O
21079329	21079329	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9585961	9585961	CD	B-NP	O
|	|	CC	I-NP	O
9/6/2003	9/6/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Artery	Artery	NNP	I-NP	O
Disease	Disease	NN	I-NP	O
.	.	.	O	O

|	|	LS	B-LST	O
|	|	:	O	B-cell_type
DIS	DIS	NNP	B-NP	I-cell_type
|	|	NNP	I-NP	I-cell_type
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/27/2003	9/27/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/26/2003	4/26/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
HOBOCK	HOBOCK	NN	B-NP	O
,	,	,	O	O
HIRAM	HIRAM	NN	B-NP	O
A.	A.	NN	I-NP	O
810-04-78-4	810-04-78-4	CD	I-NP	O
Clasonnain	Clasonnain	NNP	I-NP	O
Fre	Fre	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/5/03	6/5/03	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PERONE	PERONE	NNP	B-NP	O
,	,	,	O	O
LEN	LEN	NNP	B-NP	O
DON	DON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACYCLOVIR	ACYCLOVIR	NN	B-NP	O
400	400	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ECASA	ECASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
MCBRIEN	MCBRIEN	NN	B-NP	O
,	,	,	O	O
BENEDICT	BENEDICT	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
47453166	47453166	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.375	0.375	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
FOLATE	FOLATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FOLIC	FOLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
FOUTCH	FOUTCH	NN	B-NP	O
,	,	,	O	O
HOWARD	HOWARD	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
qam	qam	NN	I-NP	O
;	;	:	O	O
55	55	CD	B-NP	O
UNITS	UNITS	NNS	I-NP	O
qpm	qpm	NN	I-NP	O
SC	SC	NN	I-NP	O
75	75	CD	B-NP	O
UNITS	UNITS	NNS	I-NP	O
qam	qam	NN	I-NP	O
55	55	CD	B-NP	O
UNITS	UNITS	NNS	I-NP	O
qpm	qpm	NN	I-NP	O
MVI	MVI	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
W/MINERALS	W/MINERALS	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
THERAP	THERAP	NN	I-NP	I-protein
VITS/MINERALS	VITS/MINERALS	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
HEINEKEN	HEINEKEN	NNP	B-NP	O
,	,	,	O	O
WARNER	WARNER	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
DRONEY	DRONEY	NN	B-NP	O
,	,	,	O	O
PHILIP	PHILIP	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
62198790	62198790	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
SABO	SABO	NNP	B-NP	O
,	,	,	O	O
JAYSON	JAYSON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
BACTRIM	BACTRIM	NN	B-NP	O
DS	DS	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
89837063	89837063	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
GOURLEY	GOURLEY	NNP	B-NP	O
,	,	,	O	O
DAVID	DAVID	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
BASALDUA	BASALDUA	NN	B-NP	O
,	,	,	O	O
CHAS	CHAS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MVI	MVI	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
W/MINERALS	W/MINERALS	VBZ	B-VP	O
PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
90713039	90713039	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
FARALDO	FARALDO	NNP	B-NP	O
,	,	,	O	O
TOMMY	TOMMY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TESSALON	TESSALON	NN	I-NP	O
PEARLS	PEARLS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
BENZONATATE	BENZONATATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
BACTRIM	BACTRIM	NN	I-NP	O
DS	DS	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
TRIMETHOPRIM	TRIMETHOPRIM	NN	I-NP	O
/	/	SYM	I-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NN	I-NP	O
DO	DO	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
qMWF	qMWF	NN	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
SWINSON	SWINSON	NN	B-NP	O
,	,	,	O	O
RAYMUNDO	RAYMUNDO	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	B-protein
180	180	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
80	80	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/25/03	11/25/03	CD	B-NP	O
by	by	IN	B-PP	O
KEKIWI	KEKIWI	NN	B-NP	O
,	,	,	O	O
LEIF	LEIF	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
74229880	74229880	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
OXIDE	OXIDE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
241	241	CD	I-NP	O
MG	MG	NNP	I-NP	O
ELEMENTAL	ELEMENTAL	NNP	I-NP	O
MG	MG	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
400	400	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Coombes	Coombes	NNP	I-NP	O
,	,	,	O	O
WC	WC	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Altmark	Altmark	NNP	I-NP	O
,	,	,	O	O
ECHO	ECHO	NNP	B-NP	O
scheduled	schedule	VBD	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
5/17/02	5/17/02	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Cardiomyopathy	Cardiomyopathy	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Coronary	Coronary	NNP	I-NP	O
Artery	Artery	NNP	I-NP	O
Disease	Disease	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Hodgkins	Hodgkins	NNP	I-NP	O
Dx	Dx	NNP	I-NP	O
AAA	AAA	NNP	I-NP	O
repair	repair	NN	I-NP	O
1994	1994	CD	I-NP	O
Exertional	Exertional	JJ	I-NP	O
CP-epigastric	CP-epigastric	JJ	I-NP	O
1997	1997	CD	I-NP	O
:	:	:	O	O
mediast	mediast	JJ	B-NP	O
recur	recur	NN	I-NP	O
of	of	IN	B-PP	O
HD	HD	NN	B-NP	O
CVPP	CVPP	NN	I-NP	O
x1	x1	NN	I-NP	O
velban	velban	NN	I-NP	O
,	,	,	O	O
araC	araC	NN	B-NP	O
,	,	,	O	O
cisplt	cisplt	NN	B-NP	B-protein
x3	x3	NN	I-NP	I-protein
VP16	VP16	NN	I-NP	I-protein
,	,	,	O	O
vinblast	vinblast	NN	B-NP	O
,	,	,	O	O
dex	dex	NN	B-NP	O
,	,	,	O	O
cisplat	cisplat	NN	B-NP	O
3/19	3/19	CD	I-NP	O
Afib/flutter	Afib/flutter	NN	I-NP	O
h/o	h/o	NN	I-NP	O
CHF	CHF	NN	I-NP	O
from	from	IN	B-PP	O
adria	adria	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
Cath	Cath	NN	I-NP	O
with	with	IN	B-PP	O
Angiography	Angiography	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
54y	54y	LS	B-LST	O
M	M	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
recurrent	recurrent	JJ	I-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
's	's	POS	B-NP	O
Dz	Dz	NNP	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
multiple	multiple	JJ	I-NP	O
chemo/xrt	chemo/xrt	NN	I-NP	O
and	and	CC	I-NP	O
s/p	s/p	NN	I-NP	O
auto-BMT	auto-BMT	NN	I-NP	O
11/25	11/25	CD	I-NP	O
,	,	,	O	O
Cardiomyopathy	Cardiomyopathy	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EF	EF	NNP	I-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
MR	MR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
uncertain	uncertain	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
R/L	R/L	NN	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
with	with	IN	B-PP	O
angiography	angiography	NN	B-NP	O
.	.	.	O	O

Stress	Stress	NN	B-NP	O
echo	echo	AFX	O	O
-LRB-	-LRB-	HYPH	O	O
8/24	8/24	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
ECG	ECG	NN	B-NP	O
sugg	sugg	NN	I-NP	O
.	.	.	O	O

possible	possible	JJ	B-NP	O
old	old	JJ	I-NP	O
inferoseptal	inferoseptal	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
--	--	:	O	O
Hodgkin	Hodgkin	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
;	;	:	O	O
CMP	CMP	NN	B-NP	O
;	;	:	O	O
AAA	AAA	NN	B-NP	O
s/p	s/p	NN	I-NP	O
repair	repair	NN	I-NP	O
;	;	:	O	O
claudication	claudication	NN	B-NP	O
;	;	:	O	O
IDT2DM	IDT2DM	NN	B-NP	O
;	;	:	O	O
Atrial	Atrial	NNP	B-NP	O
Fib	Fib	NNP	I-NP	O
.	.	.	O	O

Meds	Med	NNS	B-NP	O
--	--	:	O	O
Losartan	Losartan	NNP	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
,	,	,	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
ER	ER	NN	I-NP	B-protein
;	;	:	O	O
Nexium	Nexium	NN	B-NP	O
;	;	:	O	O
NPH	NPH	NN	B-NP	B-protein
;	;	:	O	O
Humalog	Humalog	NNP	B-NP	O
CZI	CZI	NNP	I-NP	O
;	;	:	O	O
Folate	Folate	NNP	B-NP	O
;	;	:	O	O
Digoxin	Digoxin	NNP	B-NP	O
;	;	:	O	O
Bactrim	Bactrim	NNP	B-NP	O
MWF	MWF	NNP	I-NP	O
;	;	:	O	O
Acyclovir	Acyclovir	NNP	B-NP	O
BID	BID	NNP	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
;	;	:	O	O
MagOxide	MagOxide	NNP	B-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
--	--	:	O	O
JVP	JVP	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

IRIR	IRIR	NN	B-NP	B-protein
,	,	,	O	O
1/6	1/6	CD	B-NP	O
SM	SM	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
gallop	gallop	NN	I-NP	O
;	;	:	O	O
few	few	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
R	R	NN	I-NP	O
base	base	NN	I-NP	O
;	;	:	O	O
WWP	WWP	NN	B-NP	O
.	.	.	O	O

Cath	Cath	NNP	B-NP	O
--	--	:	O	O
Elevated	Elevated	JJ	B-NP	O
filling	fill	VBG	I-NP	O
pressures	pressure	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
RA	RA	NN	B-NP	O
15-18	15-18	CD	I-NP	O
;	;	:	O	O
PCW	PCW	NN	B-NP	O
15-20	15-20	CD	I-NP	O
;	;	:	O	O
RVP	RVP	NN	B-NP	B-protein
60/20	60/20	CD	I-NP	I-protein
;	;	:	O	O
PA	PA	NN	B-NP	O
mean	mean	NN	I-NP	O
35	35	CD	I-NP	O
;	;	:	O	O
CI	CI	NN	B-NP	O
=	=	SYM	B-VP	O
1.6	1.6	CD	B-NP	O
Coronary	Coronary	NNP	I-NP	O
--	--	:	O	O
LMain	LMain	NNP	B-NP	O
Nl	Nl	NNP	I-NP	O
;	;	:	O	O
LAD-90	LAD-90	CD	B-NP	O
%	%	NN	I-NP	O
prox	prox	NN	I-NP	O
,	,	,	O	O
80-90	80-90	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	NN	I-NP	O
,	,	,	O	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	B-ADJP	O
;	;	:	O	O
D1-80	D1-80	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
LCx	LCx	NN	B-NP	O
diffuse	diffuse	JJ	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
RCA-subtotal	RCA-subtotal	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
R	R	NN	I-NP	O
dom	dom	NN	I-NP	O
anatomy	anatomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
--	--	:	O	O
Routine	Routine	NN	B-NP	O
post	post	NN	I-NP	O
cath	cath	NN	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Increase	Increase	NNP	B-NP	O
Dilt	Dilt	NNP	I-NP	O
to	to	TO	B-PP	O
180	180	CD	B-NP	O
QD	QD	NN	I-NP	O
to	to	TO	B-VP	O
maximize	maximize	VB	I-VP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
3VD	3VD	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
consulted	consult	VBD	B-VP	O
surgery	surgery	NN	B-NP	O
re	re	NN	I-NP	O
elective	elective	JJ	I-NP	O
revascularization	revascularization	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
A/C	A/C	NN	I-NP	O
:	:	:	O	O
Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
bridge	bridge	NN	B-NP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
reduce	reduce	VBP	B-VP	O
standing	stand	VBG	I-VP	O
dose	dose	NN	B-NP	O
to	to	TO	B-PP	O
5qd	5qd	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Onc/ID	Onc/ID	NNP	I-NP	O
:	:	:	O	O
Cont	Cont	NNP	B-NP	O
Bactrim/Acyclovir	Bactrim/Acyclovir	NNP	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
all	all	DT	B-NP	O
medicines	medicine	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
--	--	:	O	O
note	note	VB	B-VP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Diltiazem	Diltiazem	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
180mg	180mg	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
Coumadin	Coumadin	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
now	now	RB	B-ADVP	O
just	just	RB	B-NP	O
one	one	CD	I-NP	O
5mg	5mg	NN	I-NP	O
tab	tab	NN	I-NP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
event	event	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
sweatiness	sweatiness	NN	B-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
PFT	PFT	NN	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
Echocardiogram	Echocardiogram	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
YUEN	YUEN	NNP	B-NP	O
,	,	,	O	O
ARTURO	ARTURO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
XN21	XN21	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/5/03	6/5/03	CD	I-NP	O
@	@	IN	B-NP	O
10	10	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

